Showing results (81-90 of 210) with videos related to

Sort By:
Pageof 21
Veterinary Parasitology|July 7, 1999
Persistent efficacy of doramectin injectable against artificially induced infections with Cooperia punctata and Dictyocaulus viviparus in cattleB E Stromberg, B W Woodward, C H Courtney, et al.
The Medical Journal of Australia|August 18, 2004
Randomised controlled trial of health assessments for older Australian veterans and war widowsJulie E Byles, Meredith Tavener, Rachel L O'Connell, et al.
Biorxiv : the Preprint Server for Biology|January 7, 2025
Haplotype editing with CRISPR/Cas9 as a therapeutic approach for dominant-negative missense mutations in <i>NEFL</i>Poorvi H Dua, Bazilco M J Simon, Chiara B E Marley, et al.
Frontiers in Cell and Developmental Biology|September 6, 2021
Allele-Specific Gene Editing Rescues Pathology in a Human Model of Charcot-Marie-Tooth Disease Type 2ECarissa M Feliciano, Kenneth Wu, Hannah L Watry, et al.
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|July 1, 1997
Second Australian National Blood Pressure Study (ANBP2). Australian Comparative Outcome Trial of ACE inhibitor- and diuretic-based treatment of hypertension in the elderly. Management Committee on behalf of the High Blood Pressure Research Council of AustraliaL M Wing, C M Reid, P Ryan, et al.
The New England Journal of Medicine|February 14, 2003
A comparison of outcomes with angiotensin-converting--enzyme inhibitors and diuretics for hypertension in the elderlyLindon M H Wing, Christopher M Reid, Philip Ryan, et al.
American Journal of Hypertension|June 1, 2005
Predictors of failure to initiate randomized treatment in a large trial of antihypertensive drug therapy in the agedMark R Nelson, Philip Ryan, Kristyn Willson, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 21, 2025
Haplotype editing with CRISPR-Cas9 as a therapeutic approach for dominant-negative missense mutations in NEFLPoorvi H Dua, Bazilco M J Simon, Chiara B E Marley, et al.
Blood Pressure|July 23, 2005
Who's really hypertensive?--Quality control issues in the assessment of blood pressure for randomized trialsChristopher M Reid, Philip Ryan, Helen Miles, et al.
Physical Review Letters|April 28, 2020
Impact of Localized Radiative Loss on Inertial Confinement Fusion ImplosionsA Pak, L Divol, C R Weber, et al.
Pageof 21